3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
11
Brain Neoplasms
3
Recurrence
2
Osteosarcoma
2
Multiple Myeloma
2
Medulloblastoma
2
Leukemia, Myeloid, Acute
2
Glioma
2
Glioblastoma
2
Diffuse Intrinsic Pontine Glioma
2
Xanthomatosis, Cerebrotendinous
1
Vaccinia
1
Uveal Melanoma
1
Transplant-Related Hematologic Malignancy
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Resectable Esophageal Cancer
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Oligodendroglioma
1
Neoplasms
1
Melanoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Kidney Neoplasms
1
Influenza, Human
1
Interventions
X-Rays
7
Specimen Handling
7
Phantoms, Imaging
7
Magnetic Resonance Spectroscopy
6
Nuclear Medicine Department, Hospital
5
Biopsy
5
Cisplatin
4
Vincristine
3
Fluorouracil
3
Doxorubicin
3
Carboplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
sodium thiosulfate
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
erdafitinib
2
ensartinib
2
Vorinostat
2
Temozolomide
2
Sorafenib
2
Oxaliplatin
2
LY3023414
2
Irinotecan
2
Gemcitabine
2
Etoposide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hepatoblastoma
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
1 year
×
Clear all
No trials found.